Table 2. Prevalence of genital infections.* .
| Female | ||||||
| HIV-1 (−) (N = 94) | HIV-1 (+) (N = 322) | |||||
| Characteristic | N | % | n | % | OR | 95% CI |
| Any treatable STI † | 7 | (8.1) | 39 | (12.3) | 1.58 | (0.67, 4.35) |
| Genital ulcer disease | 1 | (1.1) | 5 | (1.6) | 1.39 | (0.15, 66.38) |
| Syphilis | 3 | (3.2) | 10 | (3.1) | 0.97 | (0.24, 5.61) |
| Gonorrhea | 0 | (0.0) | 0 | (0.0) | NA | NA |
| Chlamydia | 1 | (1.2) | 2 | (0.6) | 0.53 | (0.03, 31.83) |
| Trichomoniasis | 3 | (3.5) | 27 | (8.5) | 2.54 | (0.75, 13.41) |
| Bacterial vaginosis | 24 | (29.6) | 89 | (32.0) | 1.12 | (0.63, 2.01) |
| Candidiasis | 1 | (1.2) | 5 | (1.6) | 1.35 | (0.15, 64.82) |
| Abnormal cervical cytology ‡ | 1 | (1.2) | 17 | (5.6) | 4.97 | (0.75, 210.06) |
*
Numbers may not add to total because of missing data.
†
Positive laboratory result for syphilis, gonorrhea, chlamydia, or trichomoniasis.
‡
CIN 1 or greater.